Filters: keyword is Disease Models [Clear All Filters]
- 2008
The exploration of rotenone as a toxin for inducing Parkinson's disease in rats, for application in BBB transport and PK-PD experiments,
J Pharmacol Toxicol Methods, vol. 57, no. 2, pp. 114-30.
- 2007
Synergistic combinations of anticonvulsant agents: what is the evidence from animal experiments?,
Epilepsia, vol. 48, no. 3, pp. 412-34.
Decreased Efficacy of GABAA-receptor modulation by midazolam in the kainate model of temporal lobe epilepsy,
Epilepsia, vol. 48, no. 7, pp. 1378-87.
Animal-to-human extrapolation of the pharmacokinetic and pharmacodynamic properties of buprenorphine,
Clin Pharmacokinet, vol. 46, no. 5, pp. 433-47.
- 2005
Pharmacokinetic-pharmacodynamic correlations and biomarkers in the development of COX-2 inhibitors,
Rheumatology (Oxford), vol. 44, no. 7, pp. 846-59.
- 2004
Pharmacodynamic analysis of the anticonvulsant effects of tiagabine and lamotrigine in combination in the rat,
Epilepsia, vol. 45, no. 5, pp. 424-35.
- 2003
Anticonvulsant drugs differentially suppress individual ictal signs: a pharmacokinetic/pharmacodynamic analysis in the cortical stimulation model in the rat,
Behav Neurosci, vol. 117, no. 5, pp. 1076-85.
- 1999
Mechanism-based modeling of adaptive changes in the pharmacodynamics of midazolam in the kindling model of epilepsy,
Pharm Res, vol. 16, no. 11, pp. 1702-9.
- 1998
Effects of repeated seizure induction on seizure activity, post-ictal and interictal behavior,
Brain Res, vol. 814, no. 1-2, pp. 199-208.
Modelling of the pharmacodynamic interaction between phenytoin and sodium valproate,
Br J Pharmacol, vol. 125, no. 7, pp. 1610-6.
- 1997
Seizure patterns in kindling and cortical stimulation models of experimental epilepsy,
Brain Res, vol. 770, no. 1-2, pp. 221-7.
- 1995
The use of intracerebral microdialysis for the determination of pharmacokinetic profiles of anticancer drugs in tumor-bearing rat brain,
Pharm Res, vol. 12, no. 12, pp. 1924-31.
- 1993
The use of intracerebral microdialysis to study blood-brain barrier transport in health, after modification and in disease,
Adv Exp Med Biol, vol. 331, pp. 257-62.



